Aquavit

Aquavit Files Additional IND for DTX-024, a New Botulinum Toxin With Microchannel Technology™ for Palmar Hyperhidrosis

Retrieved on: 
Saturday, March 18, 2023
Neurotoxin, BA, Drug development, Columbia University Vagelos College of Physicians and Surgeons, University, Hyperhidrosis, Allergan, MBA, Uniform Securities Agent State Law Exam, Doctor of Philosophy, Aquavit, Harvard Medical School, Dermatology, Investment, Patient, Physician, Ophthalmology, FINRA, Axial, Drug discovery, Knowledge, Health, FDA, IND, Clostridium botulinum, Neurology, University of Oxford, Pharmaceutical industry, Management, MD

NEW YORK, March 18, 2023 /PRNewswire/ -- Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar hyperhidrosis using its patented microchannel technology™.

Key Points: 
  • NEW YORK, March 18, 2023 /PRNewswire/ -- Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar hyperhidrosis using its patented microchannel technology™.
  • Alongside Aquavit's biosimilar program for its botulinum toxin, this will be the first in the world, indicated for palmar hyperhidrosis, approved by FDA.
  • Aquavit has been investing in proprietary delivery technologies and related intellectual property for botulinum toxin.
  • This is a strategic move that puts them ahead of the curve in the fast-growing multi-billion-dollar botulinum toxin market.

Aquavit Files Two IND's For Its Botulinum Toxin With FDA

Retrieved on: 
Friday, March 17, 2023
AB toxin, Neurotoxin, Roa, Hyperhidrosis, Toxicity, Botulinum toxin, Physician, AAD, Knowledge, FDA, IND, Clostridium botulinum, Pharmaceutical industry, Canning, Dermatology, Aquavit

NEW YORK, March 17, 2023 /PRNewswire/ -- Aquavit Holdings, the exclusive licensee of Huons Global's Botulinum Toxin in the USA and Canada, will officially unveil the Aquatox™ program at the Annual American Academy of Dermatology - 2023, the world's largest dermatology conference scheduled from March 17-21, 2023, in New Orleans, LA.

Key Points: 
  • According to The Aesthetic Society and the Global Market Insights, botulinum toxin has been the #1 non-surgical aesthetic procedure since 1999 and is still growing rapidly with only 4 companies with approved botulinum toxin in the US.
  • With a projected CAGR of 7-9%, the global botulinum toxin market in 2026 is expected to be $8.9B.
  • For several years, Aquavit has been investing in its proprietary delivery technologies and related intellectual property for botulinum toxin.
  • We plan to introduce the most innovative botulinum toxin products, uplift and modernize the treatment paradigm" said Sobin Chang, CEO of Aquavit.

Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters

Retrieved on: 
Thursday, November 3, 2022
Magistrate, Multimedia, Contempt, Defamation, Business relations, FDA, European Union Intellectual Property Office, Judgement, NY, Breach, The Honourable, Damages, CEO, Modified, EUM, Physician, Federal Trademark Dilution Act, Defendant, District court, Health, Tortious interference, Patient, Efficiency, Aquavit

NEW YORK, Nov. 3, 2022 /PRNewswire/ --Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters.

Key Points: 
  • NEW YORK, Nov. 3, 2022 /PRNewswire/ --Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters.
  • The total award to Aquavit will soon be determined by the Magistrate judge the Honorable Robert W. Lehrburger.
  • Aquavit is a high-tech pharmaceutical company that provides a comprehensive range of innovative pharmaceutical, biotech and medical device technologies.
  • Aquavit focuses on personalized medicine to improve patients' health, maximize the efficiency of the medical community, and support the pharmacoeconomics of payers.

Aquavit Pharmaceuticals, Inc. Names Timothy Sherwood Chief Operating Officer

Retrieved on: 
Tuesday, May 17, 2022
Multimedia, Patient, Investment, Senior, View, Efficiency, Sherwood, Accounting, Health, Human resources, Strategic planning, CEO, Management, Risk management, Aquavit

NEW YORK, May 17, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") today announced that it has appointed Senior Vice President Timothy Sherwood as Chief Operating Officer.

Key Points: 
  • NEW YORK, May 17, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") today announced that it has appointed Senior Vice President Timothy Sherwood as Chief Operating Officer.
  • Sherwood will also be responsible for the alignment and prioritization of Aquavit's investments and ensuring operational excellence across the company.
  • He is uniquely qualified to drive strategic prioritization and accountability within Aquavit, with a laser-focus on operational excellence," said Sobin Chang, President and CEO, Aquavit.
  • Sherwood joined Aquavit in early 2019 as Vice President of Finance and Human Resources and quickly moved into the role of Senior Vice President, Global Commercial Operations.

Aquavit Further Prevails Against Counterfeiters in U.S. Following its Recent Victory in Europe

Retrieved on: 
Monday, March 21, 2022
Somatosensory system, European Union Intellectual Property Office, Multimedia, Court, Health, CEO, Patent, 1877 U.S. Patent Office fire, EUIPO, Physician, Union, Efficiency, FDA, Instagram, Patient, Online gambling, Pharmaceutical industry, Aquavit

NEW YORK, March 21, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc ("Aquavit") continues to succeed in its intellectual property cases against counterfeiters both domestically and abroad.

Key Points: 
  • NEW YORK, March 21, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc ("Aquavit") continues to succeed in its intellectual property cases against counterfeiters both domestically and abroad.
  • The Court further reinforced Lehrburger's preview award ordering U-BioMed to pay attorney fees and costs to Aquavit in compensatory damages.
  • U-BioMed's continuous violation of the court's order in 2019 has to date accumulated the court's coercive sanction to millions of dollars.
  • Aquavit is a high-tech pharmaceutical company that provides a comprehensive range of innovative pharmaceutical, biotech and medical device technologies.

Carlton McCoy Named to The Culinary Institute of America's Board of Trustees

Retrieved on: 
Tuesday, November 9, 2021
The Culinary Institute of America, Restaurant, CIA, Court of Master Sommeliers, Food industry, Little Nell, Multimedia, Culinary Institute, HYDE, Burgess Cellars, Aquavit, BIPOC, McCoy, CO, Trustee, Alumnus, African Americans, Management

HYDE PARK, N.Y., Nov. 9, 2021 /PRNewswire/ -- The Culinary Institute of America named CarltonMcCoy, a 2006 CIA alumnus and managing partner of Lawrence Wine Estates, to its board of trustees during its annual meeting last month.

Key Points: 
  • HYDE PARK, N.Y., Nov. 9, 2021 /PRNewswire/ -- The Culinary Institute of America named CarltonMcCoy, a 2006 CIA alumnus and managing partner of Lawrence Wine Estates, to its board of trustees during its annual meeting last month.
  • "It is an honor to welcome Carlton to our board of trustees," said CIA President Dr. Tim Ryan said.
  • The CIA Board of Trustees consists of 25 highly respected leaders in the foodservice industry and business world.
  • Founded in 1946, The Culinary Institute of America is the world's premier culinary college.

Meet Big Thirst, the Distilled Spirits Industry's Most Comprehensive E-commerce Sales and Marketing Engine

Retrieved on: 
Wednesday, October 6, 2021
People, Public relations, Compliance, Breast cancer, Aquavit, ROI, Sale, Big data, Marketing, CEO, Noise, Growth, Thirst, Awareness, Technology, Intelligence, Breast Cancer Awareness Month, Time, Industry, Online shopping, Retail

The time is right for a new e-commerce company to make online sales more effective for spirits brands.

Key Points: 
  • The time is right for a new e-commerce company to make online sales more effective for spirits brands.
  • "We are excited to help distilleries and spirits brands expand their market reach faster and easier with online sales," says Matt McGinnis, CEO of Big Thirst.
  • While Big Thirst is an e-commerce start up, it is founded by passionate beverage industry veterans and is powered by a distribution and sales consultancy, Big Thirst Consulting , and a full-service marketing agency, Big Thirst Marketing .
  • Big Thirst is a full-service sales and marketing engine powered by a compliance, distribution and sales consultancy, Big Thirst Consulting, and a full-service marketing agency, Big Thirst Marketing.

Aquavit's AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO

Retrieved on: 
Wednesday, September 1, 2021
LCS, B cell, Infection, Epidermis, Technology, Aquavit, COVID-19, Efficiency, Health, Multimedia, Public health, APC, PEPP, Safety, Patient, Compliance, Patent, View, USPTO, Pharmaceutical industry, Vaccine

"Globally there has been a surge in interest in skin vaccinations; as the demand for higher immune responses and better patient compliance continues to increase.

Key Points: 
  • "Globally there has been a surge in interest in skin vaccinations; as the demand for higher immune responses and better patient compliance continues to increase.
  • We are extremely pleased to introduce AQV-1122 into our rapidly expanding intellectual property portfolio.
  • The patent addresses platform technologies directed toward innovative methods for immunizing patients against infectious diseases using microchannel technologies.
  • Our technology is not only minimally invasive, but it also facilitates a more effective immune response than traditional syringe injections.

Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions

Retrieved on: 
Tuesday, May 4, 2021
Intangible assets, Aquavit, Patent, Pharmaceutical industry, United States patent law

b'NEW YORK, May 4, 2021 /PRNewswire/ -- U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for direct application system and method for the delivery of bioactive compositions and formulations.

Key Points: 
  • b'NEW YORK, May 4, 2021 /PRNewswire/ -- U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for direct application system and method for the delivery of bioactive compositions and formulations.
  • "It has taken many years to get this patent granted.
  • As a plastic surgeon and medical innovator, I am proud of the advances we have made with Aquavit."
  • "Under the leadership of Sobin Chang, Aquavit continues to push the envelope in the aesthetic space - bridging technology and medical treatments.

Aquavit Wins a Trademark Case over AQUAGOLD in European Union Intellectual Property Office Against a Counterfeiter

Retrieved on: 
Thursday, April 15, 2021
European Union trademark law, Intellectual property law, Brand management, Product management, Intellectual property organizations, Trademark, Marketing, European Union trade mark, European Union Intellectual Property Office, Aquavit, European Union

b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.

Key Points: 
  • b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.
  • 17902149) is invalid in its entirety, as it was originally created and owned by Aquavit Pharmaceuticals, Inc. ("Aquavit").
  • The division concluded that "the [Aquavit\'s] application was totally successful and U-BioMed\'s European Union trademark has been declared invalid for all the contested goods.
  • "\nAquavit\'s microchannel technology, AQUAGOLD, was launched in 2014 at the American Academy of Dermatology, the largest dermatology conference in the world.